(Reuters) -Biotechnology firm Galapagos’ board has received non-binding offers from consortia, mainly comprised of financial investors, for its cell-therapy business, the company said on Wednesday.
(Reporting by Chandni Shah in Bengaluru; Editing by Alan Barona)
